Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of AZD5991 Alone or in Combination With Venetoclax in Relapsed or Refractory Haematologic Malignancies.

AstraZeneca · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
relapsed or refractory acute myeloid leukemia (aml), relapsed, refractory, azd5991, acute myeloid leukemia (aml), interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 877509
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.